Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism

Olafur S. Indridason, Hunter Heath, Sundeep Khosla, Daniel A. Yohay, L. Darryl Quarles

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2°HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated parathyroid hormone (PTH) suppression in 19 normocalcemic 2°HPT patients on chronic maintenance hemodialysis. We compared our results to calcium mediated PTH suppression in 12 normal volunteers, 12 patients with familial benign hypocalciuric hypercalcemia (FBHH), a disorder of abnormal calcium sensing, and 9 subjects with primary hyperparathyroidism (1°HPT), which is characterized by both calcium set-point abnormalities and parathyroid gland enlargement. We found that the 2°HPT group displayed a distinctive pattern of calcium-mediated PTH suppression characterized by a failure to normally suppress PTH at supraphysiologic ionized calcium concentrations, similar to 1°HPT, but without the rightward shift of the calcium-PTH suppression curve that characterizes calcium sensing abnormalities in FBHH and 1°HPT. In the patients with 2°HPT, hypercalcemic suppression resulted in an ending PTH (as a percent of baseline) that was significantly higher (39.8 ± 4.47%), and a slope of the calcium-PTH suppression curve that was significantly less negative (-4.8 ± 0.53), compared to respective values of 19.4 ± 1.81% (P = 0.0009) and -9.0 ± 1.02 (P = 0.001) in normals and 19.1 ± 2.49% (P = 0.001) and -9.6 ± 1.11 (P = 0.0006) in FBHH. Values of ending PTH and slope in 2°HPT patients, however, were similar to those found in 1°HPT (49.8 ± 6.35%, P = 0.21 and -4.5 ± 0.74, P = 0.72). The ionized calcium concentration required to attain half maximal PTH suppression (EC50) in 2°HPT (1.20 ± 0.02 mmol/liter) was not significantly different from normals (1.25 ± 0.01 mmol/liter, P = 0.12) but was significantly less than in 1°HPT (1.52 ± 0.02 mmol/liter, P < 0.0001) and in FBHH (1.44 ± 0.02 mmol/liter, P < 0.0001). More importantly, we found a significant linear correlation between the natural logarithm of gland size and ending PTH suppression (r = 0.71, P < 0.001) and slope of the calcium-PTH curve (r = 0.67, P = 0.002) in 2°HPT. Thus, calcium non-suppressible PTH secretion in 2°HPT does not represent a simple set-point error, but rather correlates with the degree of parathyroid gland enlargement.

Original languageEnglish (US)
Pages (from-to)1663-1671
Number of pages9
JournalKidney International
Volume50
Issue number5
StatePublished - Nov 1996

Fingerprint

Secondary Hyperparathyroidism
Parathyroid Hormone
Calcium
Parathyroid Glands
Primary Hyperparathyroidism
Hypocalciuric hypercalcemia, familial, type 1
Renal Dialysis
Healthy Volunteers

ASJC Scopus subject areas

  • Nephrology

Cite this

Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. / Indridason, Olafur S.; Heath, Hunter; Khosla, Sundeep; Yohay, Daniel A.; Quarles, L. Darryl.

In: Kidney International, Vol. 50, No. 5, 11.1996, p. 1663-1671.

Research output: Contribution to journalArticle

Indridason, Olafur S. ; Heath, Hunter ; Khosla, Sundeep ; Yohay, Daniel A. ; Quarles, L. Darryl. / Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. In: Kidney International. 1996 ; Vol. 50, No. 5. pp. 1663-1671.
@article{483d69549d6a4c08b4ec2e1eb8d21df6,
title = "Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism",
abstract = "To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2°HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated parathyroid hormone (PTH) suppression in 19 normocalcemic 2°HPT patients on chronic maintenance hemodialysis. We compared our results to calcium mediated PTH suppression in 12 normal volunteers, 12 patients with familial benign hypocalciuric hypercalcemia (FBHH), a disorder of abnormal calcium sensing, and 9 subjects with primary hyperparathyroidism (1°HPT), which is characterized by both calcium set-point abnormalities and parathyroid gland enlargement. We found that the 2°HPT group displayed a distinctive pattern of calcium-mediated PTH suppression characterized by a failure to normally suppress PTH at supraphysiologic ionized calcium concentrations, similar to 1°HPT, but without the rightward shift of the calcium-PTH suppression curve that characterizes calcium sensing abnormalities in FBHH and 1°HPT. In the patients with 2°HPT, hypercalcemic suppression resulted in an ending PTH (as a percent of baseline) that was significantly higher (39.8 ± 4.47{\%}), and a slope of the calcium-PTH suppression curve that was significantly less negative (-4.8 ± 0.53), compared to respective values of 19.4 ± 1.81{\%} (P = 0.0009) and -9.0 ± 1.02 (P = 0.001) in normals and 19.1 ± 2.49{\%} (P = 0.001) and -9.6 ± 1.11 (P = 0.0006) in FBHH. Values of ending PTH and slope in 2°HPT patients, however, were similar to those found in 1°HPT (49.8 ± 6.35{\%}, P = 0.21 and -4.5 ± 0.74, P = 0.72). The ionized calcium concentration required to attain half maximal PTH suppression (EC50) in 2°HPT (1.20 ± 0.02 mmol/liter) was not significantly different from normals (1.25 ± 0.01 mmol/liter, P = 0.12) but was significantly less than in 1°HPT (1.52 ± 0.02 mmol/liter, P < 0.0001) and in FBHH (1.44 ± 0.02 mmol/liter, P < 0.0001). More importantly, we found a significant linear correlation between the natural logarithm of gland size and ending PTH suppression (r = 0.71, P < 0.001) and slope of the calcium-PTH curve (r = 0.67, P = 0.002) in 2°HPT. Thus, calcium non-suppressible PTH secretion in 2°HPT does not represent a simple set-point error, but rather correlates with the degree of parathyroid gland enlargement.",
author = "Indridason, {Olafur S.} and Hunter Heath and Sundeep Khosla and Yohay, {Daniel A.} and Quarles, {L. Darryl}",
year = "1996",
month = "11",
language = "English (US)",
volume = "50",
pages = "1663--1671",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism

AU - Indridason, Olafur S.

AU - Heath, Hunter

AU - Khosla, Sundeep

AU - Yohay, Daniel A.

AU - Quarles, L. Darryl

PY - 1996/11

Y1 - 1996/11

N2 - To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2°HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated parathyroid hormone (PTH) suppression in 19 normocalcemic 2°HPT patients on chronic maintenance hemodialysis. We compared our results to calcium mediated PTH suppression in 12 normal volunteers, 12 patients with familial benign hypocalciuric hypercalcemia (FBHH), a disorder of abnormal calcium sensing, and 9 subjects with primary hyperparathyroidism (1°HPT), which is characterized by both calcium set-point abnormalities and parathyroid gland enlargement. We found that the 2°HPT group displayed a distinctive pattern of calcium-mediated PTH suppression characterized by a failure to normally suppress PTH at supraphysiologic ionized calcium concentrations, similar to 1°HPT, but without the rightward shift of the calcium-PTH suppression curve that characterizes calcium sensing abnormalities in FBHH and 1°HPT. In the patients with 2°HPT, hypercalcemic suppression resulted in an ending PTH (as a percent of baseline) that was significantly higher (39.8 ± 4.47%), and a slope of the calcium-PTH suppression curve that was significantly less negative (-4.8 ± 0.53), compared to respective values of 19.4 ± 1.81% (P = 0.0009) and -9.0 ± 1.02 (P = 0.001) in normals and 19.1 ± 2.49% (P = 0.001) and -9.6 ± 1.11 (P = 0.0006) in FBHH. Values of ending PTH and slope in 2°HPT patients, however, were similar to those found in 1°HPT (49.8 ± 6.35%, P = 0.21 and -4.5 ± 0.74, P = 0.72). The ionized calcium concentration required to attain half maximal PTH suppression (EC50) in 2°HPT (1.20 ± 0.02 mmol/liter) was not significantly different from normals (1.25 ± 0.01 mmol/liter, P = 0.12) but was significantly less than in 1°HPT (1.52 ± 0.02 mmol/liter, P < 0.0001) and in FBHH (1.44 ± 0.02 mmol/liter, P < 0.0001). More importantly, we found a significant linear correlation between the natural logarithm of gland size and ending PTH suppression (r = 0.71, P < 0.001) and slope of the calcium-PTH curve (r = 0.67, P = 0.002) in 2°HPT. Thus, calcium non-suppressible PTH secretion in 2°HPT does not represent a simple set-point error, but rather correlates with the degree of parathyroid gland enlargement.

AB - To determine the relative importance of parathyroid gland enlargement and alterations in calcium sensing (set-point changes) in the pathogenesis of uremic secondary hyperparathyroidism (2°HPT), we investigated the relationship between estimates of parathyroid gland size and calcium-mediated parathyroid hormone (PTH) suppression in 19 normocalcemic 2°HPT patients on chronic maintenance hemodialysis. We compared our results to calcium mediated PTH suppression in 12 normal volunteers, 12 patients with familial benign hypocalciuric hypercalcemia (FBHH), a disorder of abnormal calcium sensing, and 9 subjects with primary hyperparathyroidism (1°HPT), which is characterized by both calcium set-point abnormalities and parathyroid gland enlargement. We found that the 2°HPT group displayed a distinctive pattern of calcium-mediated PTH suppression characterized by a failure to normally suppress PTH at supraphysiologic ionized calcium concentrations, similar to 1°HPT, but without the rightward shift of the calcium-PTH suppression curve that characterizes calcium sensing abnormalities in FBHH and 1°HPT. In the patients with 2°HPT, hypercalcemic suppression resulted in an ending PTH (as a percent of baseline) that was significantly higher (39.8 ± 4.47%), and a slope of the calcium-PTH suppression curve that was significantly less negative (-4.8 ± 0.53), compared to respective values of 19.4 ± 1.81% (P = 0.0009) and -9.0 ± 1.02 (P = 0.001) in normals and 19.1 ± 2.49% (P = 0.001) and -9.6 ± 1.11 (P = 0.0006) in FBHH. Values of ending PTH and slope in 2°HPT patients, however, were similar to those found in 1°HPT (49.8 ± 6.35%, P = 0.21 and -4.5 ± 0.74, P = 0.72). The ionized calcium concentration required to attain half maximal PTH suppression (EC50) in 2°HPT (1.20 ± 0.02 mmol/liter) was not significantly different from normals (1.25 ± 0.01 mmol/liter, P = 0.12) but was significantly less than in 1°HPT (1.52 ± 0.02 mmol/liter, P < 0.0001) and in FBHH (1.44 ± 0.02 mmol/liter, P < 0.0001). More importantly, we found a significant linear correlation between the natural logarithm of gland size and ending PTH suppression (r = 0.71, P < 0.001) and slope of the calcium-PTH curve (r = 0.67, P = 0.002) in 2°HPT. Thus, calcium non-suppressible PTH secretion in 2°HPT does not represent a simple set-point error, but rather correlates with the degree of parathyroid gland enlargement.

UR - http://www.scopus.com/inward/record.url?scp=0029856259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029856259&partnerID=8YFLogxK

M3 - Article

C2 - 8914034

AN - SCOPUS:0029856259

VL - 50

SP - 1663

EP - 1671

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -